Leidos (LDOS)
(Delayed Data from NYSE)
$166.39 USD
+1.24 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $166.39 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$166.39 USD
+1.24 (0.75%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $166.39 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Zacks News
Lockheed (LMT) Surges 24% YTD: Should You Buy Now or Later?
by Aparajita Dutta
A prudent investor should refrain from buying Lockheed (LMT) now, considering its premium valuation. Those who own it might continue to do so.
CACI International (CACI) Secures Army Contract Worth $239M
by Zacks Equity Research
CACI International (CACI) secures a contract worth $239 million from the U.S. Army to provide intelligence support throughout Europe and Africa.
Science Applications (SAIC) Secures Navy Contracts Worth $58.2M
by Zacks Equity Research
Science Applications (SAIC) secures three Navy contracts worth $58.2 million, which are set to provide support for the Navy's jammer assets and electronic warfare programs.
Leidos (LDOS) Wins a $191M Deal to Upgrade US Army's Software
by Zacks Equity Research
Leidos (LDOS) gets a $191 million contract for software modernization to support the U.S. Army.
Science Applications (SAIC) Secures Navy Contract Worth $120M
by Zacks Equity Research
Science Applications (SAIC) secures a $120 million contract from Naval Supply Systems Command to support the latter's fleet training missions.
Is It Worth Investing in Leidos (LDOS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Leidos (LDOS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LDOS vs. EADSY: Which Stock Is the Better Value Option?
by Zacks Equity Research
LDOS vs. EADSY: Which Stock Is the Better Value Option?
Why Leidos (LDOS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Leidos Holdings, Inc. (LDOS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Leidos (LDOS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks.com featured highlights include Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare
by Zacks Equity Research
Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare have been highlighted in this Screen of The Week article.
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.
Leidos (LDOS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Leidos (LDOS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks.com featured highlights include HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies
by Zacks Equity Research
HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies are part of the Zacks Screen of the Week article.
3 Reasons Why Growth Investors Shouldn't Overlook Leidos (LDOS)
by Zacks Equity Research
Leidos (LDOS) possesses solid growth attributes, which could help it handily outperform the market.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy Leidos (LDOS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Aerospace Stocks Lagging Leidos (LDOS) This Year?
by Zacks Equity Research
Here is how Leidos (LDOS) and Lockheed Martin (LMT) have performed compared to their sector so far this year.
Huntington Ingalls (HII) Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Huntington Ingalls (HII) Q2 revenues of $2.98 billion beat the Zacks Consensus Estimate by 4.7%. The company raised its 2024 revenue guidance for the Mission Technologies business segment.
5 Top-Ranked Dividend Stocks for Growth of Your Portfolio
by Sweta Killa
HCA Healthcare (HCA), Taiwan Semiconductor (TSM), H&R Block (HRB), Leidos Holdings. (LDOS) and The TJX Companies (TJX) could be solid choices for your portfolio.
Boeing's (BA) Q2 Earnings Miss Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Boeing's (BA) Q2 revenues of $16.87 billion miss the Zacks Consensus Estimate by 3.5% and decline 15% from the year-ago quarter's reported figure.
Leidos Holdings (LDOS) Beats on Q2 Earnings, Ups '24 EPS View
by Zacks Equity Research
Leidos Holdings' (LDOS) Q2 revenues of $4.13 billion beat the Zacks Consensus Estimate by 2.2%. The top line also improves 7.7% year over year.
Leidos (LDOS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Leidos (LDOS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Leidos (LDOS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Leidos (LDOS) delivered earnings and revenue surprises of 16.37% and 2.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Leidos (LDOS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Leidos (LDOS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Will Segmental Sales Aid Huntington Ingalls' (HII) Q2 Earnings?
by Zacks Equity Research
Huntington Ingalls' (HII) Q2 results are likely to reflect a solid sales performance across its business segments, along with the benefits of margin improvement at its shipbuilding business.